EE200300530A - EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks - Google Patents

EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks

Info

Publication number
EE200300530A
EE200300530A EEP200300530A EEP200300530A EE200300530A EE 200300530 A EE200300530 A EE 200300530A EE P200300530 A EEP200300530 A EE P200300530A EE P200300530 A EEP200300530 A EE P200300530A EE 200300530 A EE200300530 A EE 200300530A
Authority
EE
Estonia
Prior art keywords
antibacterial
agents
preparation
new anti
identifying new
Prior art date
Application number
EEP200300530A
Other languages
English (en)
Inventor
Mayer Frank
Original Assignee
Novologix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10129870A external-priority patent/DE10129870A1/de
Application filed by Novologix Gmbh filed Critical Novologix Gmbh
Publication of EE200300530A publication Critical patent/EE200300530A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EEP200300530A 2001-04-30 2002-04-22 EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks EE200300530A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10121145 2001-04-30
DE10129870A DE10129870A1 (de) 2001-04-30 2001-06-21 Antibakterielles Mittel
PCT/EP2002/004410 WO2002087554A2 (de) 2001-04-30 2002-04-22 Ef-tu-bindende substanzen als ntibakterielles mittel

Publications (1)

Publication Number Publication Date
EE200300530A true EE200300530A (et) 2004-04-15

Family

ID=26009202

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300530A EE200300530A (et) 2001-04-30 2002-04-22 EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks

Country Status (17)

Country Link
EP (1) EP1397157A2 (et)
JP (1) JP2004534016A (et)
CN (1) CN1298739C (et)
AU (1) AU2002302555B2 (et)
BG (1) BG108399A (et)
BR (1) BR0209282A (et)
CA (1) CA2445995A1 (et)
CZ (1) CZ20033271A3 (et)
EE (1) EE200300530A (et)
HU (1) HUP0401586A3 (et)
IL (1) IL158627A0 (et)
MX (1) MXPA03009954A (et)
NZ (1) NZ529662A (et)
PL (1) PL366836A1 (et)
RU (1) RU2003134636A (et)
SK (1) SK14792003A3 (et)
WO (1) WO2002087554A2 (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229645A1 (de) * 2002-07-02 2004-05-19 Kuchenreuther, Ulrich, Dr. Zellaufschluss von Bakterien
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
JP5852569B2 (ja) 2009-07-31 2016-02-03 タール ファーマシューティカルズ,インコーポレイテッド 結晶化方法および生物学的利用能
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
CN105218668B (zh) * 2015-10-30 2020-03-24 山东农业大学 马耳他型布氏杆菌的EF-Tu蛋白单克隆抗体MAb及其制备方法与应用
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466251A1 (en) * 1990-07-10 1992-01-15 Gist-Brocades N.V. Elfamycin-resistant mutants
AU2717699A (en) * 1998-01-23 1999-08-09 Akzo Nobel N.V. Ef-tu mrna as a marker for viability of bacteria
US6451556B1 (en) * 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu

Also Published As

Publication number Publication date
PL366836A1 (en) 2005-02-07
BR0209282A (pt) 2004-07-27
CZ20033271A3 (en) 2004-06-16
JP2004534016A (ja) 2004-11-11
MXPA03009954A (es) 2005-07-25
EP1397157A2 (de) 2004-03-17
HUP0401586A3 (en) 2005-06-28
SK14792003A3 (sk) 2004-07-07
WO2002087554A3 (de) 2003-01-30
CN1298739C (zh) 2007-02-07
NZ529662A (en) 2006-08-31
CN1518455A (zh) 2004-08-04
RU2003134636A (ru) 2005-04-20
AU2002302555B2 (en) 2007-08-23
BG108399A (bg) 2004-08-31
WO2002087554A2 (de) 2002-11-07
HUP0401586A2 (hu) 2004-11-29
IL158627A0 (en) 2004-05-12
WO2002087554B1 (de) 2005-01-27
CA2445995A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
IS2940B (is) Mótefni gegn CD40
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
NO20041907L (no) Angiopoietin-2 spesifikke bindinsmidler
AR028110A1 (es) Nuevo proceso
ITRM20020186A0 (it) Interruttore elettromagnetico per avviatore.
NO20042000D0 (no) Fremgangsmate for flerbrukerinnhold
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
DE60234410D1 (de) Fehlerschätzendes verfahren
BR0318172B1 (pt) "dispositivo de combinaÇço de impedÂncia, e, mÉtodo para fabricar o mesmo"
EE200300530A (et) EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks
DE60236534D1 (de) Verbesserte herbizidzusammensetzung
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
PT1281707E (pt) Processo para a preparacao de isobenzofuranos 5-substituidos
DE60135471D1 (de) H3 agonisten oder antagonisten
DE50213834D1 (de) Trennmittel
AU2003255282A1 (en) Methods for the identification of agents with anti-microbial action
NO20013007D0 (no) Impregneringsmiddel og sett og fremgangsmåte for dets fremstilling og anvendelse
ES1050514Y (es) Moldeadora de hormigon para cunetas.
ES1050665Y (es) Cañizo mejorado para cercado
SE0104471D0 (sv) New method
NO20033515D0 (no) Impregneringsmiddel
AU1936P (en) Ivory Princess Prunus persica
ES1047454Y (es) Maquina para la fabricacion de piezas ceramicas cerradas.